Applied dna to report first quarter fiscal 2023 financial results and host investor conference call and webcast on thursday, february 9, 2023

Stony brook, n.y.--( business wire )--applied dna sciences, inc. (nasdaq: apdn) (“applied dna” or the “company”), a leader in polymerase chain reaction ("pcr")-based technologies, today announced that it will release financial results for the three months ended december 31, 2022, after the market closes on thursday, february 9, 2023. the company will host a conference call for the investment community to discuss its results and answer questions at 4:30 p.m. et.
APDN Ratings Summary
APDN Quant Ranking